Recent Advances in the Management of Gastro-Oesophageal Reflux Disease

Reference

• Savary M, Miller G. The esophagus-handbook and atlas of endoscopy. Verlag Gassmann AG, Solothurn, Switzerland 1978
   Google Scholar
• Tytgat G NJ. Drug therapy of reflux oesophagitis: an update. Scand J Gastroenterol 1989; 24: 38–49, Suppl 168
   Web of Science ®Google Scholar
• Johnson L F, DeMeester TR. Evaluation of elevation of the head of the bed, bethanechol and antacid foam tablets on gastroesophageal reflux. Dig Dis Sci 1981; 21: 139–145
   Google Scholar
• Hamilton J W, Boisen R J, Hamilton J W, et al. Sleeping on a wedge diminishes exposure of the esophagus to refluxed acid. Dig Dis Sci 1988; 33: 518–522
   PubMed Web of Science ®Google Scholar
• Harvey R F, Gordon P C, Hadley N, et al. Effects of sleeping with the bed-head raised and of ranitidine in patients with severe peptic oesophagitis. Lancet 1987; 2: 1200–1203
   PubMed Web of Science ®Google Scholar
• O'Hanrahan T, Marples M, Blount A, et al. Weight reduction and gastro-oesophageal reflux. Gut 1989; 30: A1491
   Web of Science ®Google Scholar
• Thomas F B, Steinbaugh T J, Fromkes J J, et al. Inhibitory effect of coffee on lower esophageal sphincter pressure. Gastroenterology 1980; 79: 1262–1266
   PubMed Web of Science ®Google Scholar
• Lloyd D A, Borda IT. Food-induced heartburn: effect of osmolarity. Gastroenterology 1981; 80: 740–741
   PubMed Web of Science ®Google Scholar
• Hogan W J, Viegas S R, Winship DH. Ethanol-induced acute esophageal motor dysfunction. J Appl Physiol 1972; 32: 755–760
   PubMed Web of Science ®Google Scholar
• Schürer-Maly C-C, Varga L, Koelz Halter F. Smoking and pH response to H2-receptor antagonists. Scand J Gastroenterol 1989; 24: 1172–1178
   PubMed Web of Science ®Google Scholar
• Richter J E, Castell DO. Drugs, foods, and other substances in the cause and treatment of reflux esophagitis. Med Clin North Am 1981; 65: 1223–1234
   PubMed Web of Science ®Google Scholar
• Tytgat G NJ, Nio CY. The medical therapy of reflux oesophagitis. Balliere's Clin Gastroenterol 1987; 1: 1–17
   Google Scholar
• Verlinden M. Review: a role for gastrointestinal prokinetic agents in the treatment of reflux oesophagitis?. Aliment Pharmacol Ther 1989; 3: 113–133
   PubMed Web of Science ®Google Scholar
• Bright-Asare P, El-Bassoussi M. Cimetidine, metoclopramide, or placebo in the treatment of symptomatic gastroesophageal reflux. J Clin Gastroenterol 1980; 2: 149–156
   PubMed Web of Science ®Google Scholar
• Guslandi M, Testoni P A, Passaretti S, et al. Ranitidine vs metoclopramide in the medical treatment of reflux esophagitis. Hepatogastroenterology 1983; 30: 96–98
   PubMed Web of Science ®Google Scholar
• Masci E, Testoni P A, Passaretti S, et al. Comparison of ranitidine, domperidone maleate and ranitidine + domperidone maleate in the short-term treatment of reflux oesophagitis. Drugs Exp Clin Res 1985; 11: 687–692
   PubMedGoogle Scholar
• Blackwell J N, Heading R C, Fettes MR. Effect of domperidone in lower esophageal sphincter pressure and gastroesophageal reflux in patients with peptic esophagitis. International Congress and Symposium. Royal Society of Medicine, 1981; 57–65, Series No. 36
   Google Scholar
• van Nueten J M, van Daele P GH, Reyntjes A J, (1984) Gastrointestinal motility stimulating properties of cisapride, a non-antidopaminergic, non-cholinergic compound. Proceedings of the Ninth International Symposium on GI Motility, Aix-en-Provence. September, 1983, C Roman, et al. MTP Press, Lancaster, 513–520
   Google Scholar
• Creytens G. Effects of cisapride on gastro-oesophageal reflux symptoms in hiatal-hernia patients. Digestion 1986; 34: 145
   Web of Science ®Google Scholar
• Hüttemann W. Cisapride in the treatment of oesophagitis. A placebo-controlled trial. Progress in the treatment of gastro-intestinal motility disorders: the role of cisapride, AG Johnson, G Lux. Excerpta Medica, Amsterdam 1988; 56–63
   Google Scholar
• Baldi F, Bianchi-Porro G, Dobrilla G, et al. Cisapride versus placebo in reflux esophagitis. A multicenter double-blind trial. J Clin Gastroenterol 1988; 10: 614–618
   PubMed Web of Science ®Google Scholar
• Janisch H D, Hüttemann W, Bouzo MH. Cisapride versus ranitidine in the treatment of reflux esophagitis. Hepatogastroenterology 1988; 35: 125–127
   PubMedGoogle Scholar
• Evreux M, Filoche B, Fournet J, et al. Endoscopic and clinical evaluation of cisapride and cimetidine in reflux oesophagitis. Gastroenterology 1988; 94: A120
   Web of Science ®Google Scholar
• Galmiche J P, Brandstatter G, Evreux M, et al. Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: a double-blind controlled trial. Gut 1988; 29: 675–681
   PubMed Web of Science ®Google Scholar
• Blum A L, Verlinden M. The Eurocis trialists. Cisapride prevents relapse of reflux esophagitis. Gastroenterology 1990; 89: A22
   Google Scholar
• Verlinden M. Healing and prevention of relapse of reflux oesophagitis by cisapride. Gastroenterology 1990; 89: A144
   Google Scholar
• Weberg R, Berstad A. Symptomatic effect of a low-dose antacid regimen in reflux oesophagitis. Scand J Gastroenterol 1989; 24: 401–406
   PubMed Web of Science ®Google Scholar
• Grove O, Bekker C, Jeppe-Hansen M H, et al. Ranitidine and high-dose antacid in reflux oesophagitis. A randomized, placebo-controlled trial. Scand J Gastroenterol 1985; 20: 457–461
   PubMed Web of Science ®Google Scholar
• Beeley M, Warner JO. Medical treatment of symptomatic hiatus hernia with low-density compounds. Curr Med Res Opin 1972; 1: 63–69
   PubMedGoogle Scholar
• Tytgat G NJ. Clinical efficacy of sucralfate in reflux esophagitis. Comparison with cimetidine. Am J Med 1987; 83: 38–42, Suppl 3B
   PubMed Web of Science ®Google Scholar
• Simon B, Dammann H-G, Müller P. Sucralfate in the treatment of reflux esophagitis in adults: an update. Scand J Gastroenterol 1989; 24: 37–41, Suppl 156
   Web of Science ®Google Scholar
• Carling L, Cronstedt J, Engqvist A, et al. Sucralfate versus placebo in reflux esophagitis. Scand J Gastroenterol 1988; 23: 1117–1124
   PubMed Web of Science ®Google Scholar
• Laitinen S, Stahlberg M, Kairaluoma M I, et al. Sucralfate versus alginate/antacid in reflux esophagitis. Scand J Gastroenterol 1985; 20: 229–232
   PubMed Web of Science ®Google Scholar
• Hameeteman W, Van Den Boomgaard D M, Dekker W, et al. Sucralfate versus cimetidine in reflux esophagitis: a single blind multicentre study. J Clin Gastroenterol 1987; 9: 390–394
   PubMed Web of Science ®Google Scholar
• Simon B, Beckenbach H P, Daake H, et al. Reflux oesophagitis. Wirksamkeitsvergleich von sucralfat und ranitidin. MMW 1988; 130: 152–154
   Google Scholar
• Ros E, Pujol A, Bordas J M, Grande L. Efficacy of sucralfate in refractory reflux esophagitis. Results of a pilot study. Scand J Gastroenterol 1989; 24: 49–55, Suppl 156
   Web of Science ®Google Scholar
• Herrera J L, Shay S S, McCabe M, et al. Sucralfate used as adjunctive therapy in patients with severe erosive peptic esophagitis resulting from gastroesophageal reflux. Am J Gastroenterol 1990; 85: 1335–1338
   PubMed Web of Science ®Google Scholar
• Schotborgh R H, Hameeteman W, Dekker W, et al. Combination therapy of sucralfate and cimetidine, compared with sucralfate monotherapy, in patients with peptic reflux esophagitis. Am J Med 1989; 86: 77–80, Suppl 6A
   PubMed Web of Science ®Google Scholar
• Tay H P, Chaparala R C, Harmon J W, et al. Bismuth subsalicylate reduces peptic injury of the oesophagus in rabbits. Gut 1990; 31: 11–16
   PubMed Web of Science ®Google Scholar
• Balan G, Sandulescu E, Cijevschi C, et al. De-Nol in the treatment of reflux esophagitis. Rev Med Chir Soc Med Nat Iasi 1989; 93: 67–70
   PubMedGoogle Scholar
• Borkent M V, Bekker JA. Treatment of ulcerative reflux oesophagitis with colloidal bismuth subcitrate in combination with cimetidine. Gut 1988; 29: 385–389
   PubMed Web of Science ®Google Scholar
• Smart H L, James P D, Atkinson M, Hawkey CJ. Treatment of reflux oesophagitis with trimoprostil. Digestion 1989; 44: 52–56
   PubMed Web of Science ®Google Scholar
• Hawkey C J, Rampton DS. Prostaglandins and the gastrointestinal mucosa: are they important in disease or treatment?. Gastroenterology 1985; 89: 1162–1188
   PubMed Web of Science ®Google Scholar
• Goldberg H I, Dodds W J, Gee S, et al. Role of acid and pepsin in acute experimental esophagitis. Gastroenterology 1969; 56: 223–230
   PubMed Web of Science ®Google Scholar
• Johansson K E, Tibbling L. Gastric secretion and reflux pattern in reflux esophagitis before and during ranitidine treatment. Scand J Gastroenterol 1986; 21: 776–778
   Web of Science ®Google Scholar
• Colin-Jones DG. Histamine-2-receptor antagonists in gastro-oesophageal reflux. Gut 1989; 30: 1305–1308
   PubMed Web of Science ®Google Scholar
• Koelz HR. Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs. An analysis of randomized clinical trials. Scand J Gastroenterol 1989; 24: 25–36, Suppl 156
   Web of Science ®Google Scholar
• Wesdorp I CE, Dekker W, Klinkenberg-Knol EC. Treatment of reflux oesophagitis with ranitidine. Gut 1983; 24: 921–924
   PubMed Web of Science ®Google Scholar
• Ferguson R, Dronfield M W, Atkinson M. Cimetidine in treatment of reflux oesophagitis with peptic stricture. Br Med J 1979; 2: 472–474
   PubMed Web of Science ®Google Scholar
• Jansen J BMJ, Baak L C, Lamers C BHW. Effect of increasing doses of ranitidine on exposure of the oesophagus to gastric acid in patients with reflux oesophagitis. Scand J Gastroenterol 1988; 23: 2–5, Suppl 154
   Web of Science ®Google Scholar
• Johnson N J, Boyd E JS, Mills J G, Wood JR. Acute treatment of reflux oesophagitis: a multi-centre trial to compare 150 mg ranitidine b.d. with 300 mg ranitidine q.d.s. Aliment Pharmacol Ther 1989; 3: 259–266
   PubMed Web of Science ®Google Scholar
• Koelz H R, Birchler R, Bretholz A, et al. Healing and relapse of reflux esophagitis during treatment with ranitidine. Gastroenterology 1986; 91: 1198–1205
   PubMed Web of Science ®Google Scholar
• Wesdorp E, Bartelsman J, Pape K, et al. Oral cimetidine in reflux esophagitis: a double blind controlled trial. Gastroenterology 1978; 74: 821–824
   PubMed Web of Science ®Google Scholar
• Collen M J, Lewis J H, Benjamin SB. Gastric acid hypersecretion in refractory gastroesophageal reflux disease. Gastroenterology 1990; 98: 654–661
   PubMed Web of Science ®Google Scholar
• Jansen J BMJ, Baak L C, Lamers C BHW. Effect of increasing doses of ranitidine on exposure of the oesophagus to gastric acid in patients with reflux oesophagitis. Scand J Gastroenterol 1988; 23: 2–5, Suppl 154
   Web of Science ®Google Scholar
• Klinkenberg-Knol E C, Festen H PM, Meuwissen G GM. The effects of omeprazole and ranitidine on 24-hour pH in the distal oesophagus of patients with reflux oesophagitis. Aliment Pharmacol Ther 1988; 2: 221–227
   PubMed Web of Science ®Google Scholar
• Temple J G, Bradby G V, O'Connor F, et al. Cimetidine and metoclopramide in oesophageal reflux disease. Br Med J 1983; 286: 1863–1864
   PubMed Web of Science ®Google Scholar
• Liebermann D A, Keefe EB. Treatment of severe reflux esophagitis with cimetidine and metoclopramide. Ann Intern Med 1986; 104: 21–26
   PubMed Web of Science ®Google Scholar
• Lind T, Cederberg C, Ekenved G, Olbe L. Inhibition of basal and betazole and sham-feeding-induced acid secretion by omeprazole in man. Scand J Gastroenterol 1986; 21: 1004–1010
   PubMed Web of Science ®Google Scholar
• Hetzel D J, Dent J, Reed W D, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988; 95: 903–912
   PubMed Web of Science ®Google Scholar
• Klinkenberg-Knol E C, Jansen J MBJ, Festen H PM, Meuwissen S GM, Lamers C BHW. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis. Lancet 1987; 1: 349–351
   PubMed Web of Science ®Google Scholar
• Havelund T, Laursen L S, Skoubo-Kristensen E, et al. Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial. Br Med J 1988; 296: 89–92
   PubMed Web of Science ®Google Scholar
• Vantrappen G, Rutgeerts L, Schurmans P, Coenegrachts J-L. Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux oesophagitis. Dig Dis Sci 1988; 33: 523–529
   PubMed Web of Science ®Google Scholar
• Sandmark S, Carlsson R, Fausa O, Lundell L. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results from a double-blind, randomized Scandinavian multicenter study. Scand J Gastroenterol 1988; 23: 625–632
   PubMed Web of Science ®Google Scholar
• Lundell L, Backman L, Ekström P, et al. Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to ‘standard doses’ of H2-receptor antagonists. Aliment Pharmacol Ther 1990; 4: 145–157
   PubMed Web of Science ®Google Scholar
• Hameeteman W, Tytgat G NJ. Healing of chronic Barrett ulcers with omeprazole. Am J Gastroenterol 1986; 81: 764–766
   PubMed Web of Science ®Google Scholar
• Lee F I, Isaacs P ET. Barrett's ulcer: response to standard dose ranitidine, high dose ranitidine, and omeprazole. Am J Gastroenterol 1988; 83: 914–917
   PubMed Web of Science ®Google Scholar
• Klinkenberg-Knol E C, Jansen J BMJ, Lamers C BHW, et al. Use of omeprazole in the management of reflux oesophagitis resistant to H2-receptor antagonists. Scand J Gastroenterol 1989; 24: 88–93, Suppl 166
   Web of Science ®Google Scholar
• Havu N. Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion 1986; 35: 42–55, Suppl 1
   PubMed Web of Science ®Google Scholar
• Lieberman DA. Medical therapy for chronic reflux esophagitis. Arch Intern Med 1987; 147: 1717–1721
   PubMedGoogle Scholar
• Glise H. Healing, relapse rates and prophylaxis of reflux esophagitis. Scand J Gastroenterol 1989; 24: 57–64, Suppl 156
   PubMed Web of Science ®Google Scholar
• Klinkenberg-Knol E C, Meuwissen S GM. Combined gastric and oesophageal 24-hour pH monitoring and oesophageal manometry in patients with reflux disease resistant to treatment with omeprazole. Aliment Pharmacol Ther 1990; 4: 485–495
   PubMed Web of Science ®Google Scholar
• Koelz H R, Bircher R, Bron R. Behandlung der Refluxösophagitis mit Ranitidine. Eine multi-zentrische, prospektive Studie. Schweiz Med Wochenschr 1982; 112: 1901–1904
   PubMedGoogle Scholar
• Ottenjann R, Siewert J R, Heilman K, Neiss A, Doepper H. Treatment of reflux oesophagitis. Results of a multicenter trial with cimetidine. In: Siewert JR, Hölscher AH, eds. Proceedings of the International Week, Munich, 14–19 September 1986; 190
   Google Scholar
• Berlin R, Ebel D, Cook T. Famotidine 20 HS and 40 HS versus placebo in the maintenance therapy of reflux esophagitis: results of a double-blind, multi-center trial. Gastroenterology 1989; 96: A39
   Google Scholar
• Castell DO. Long-term therapy for chronic gastro-esophageal reflux. Arch Intern Med 1987; 147: 1701–1702
   PubMedGoogle Scholar
• Dent J, Klinkenberg-Knol E, Elm G, et al. Omeprazole in the long term treatment of patients with reflux esophagitis refractory to histamine H2-receptor antagonists. Gastroenterology International 1988, Suppl 1, ref 847
   Web of Science ®Google Scholar
• Antonson C W, Robinson M G, Hawkins T M, McIntosh D L, Campbell DR. High doses of histamine antagonists do not prevent relapses of peptic esophagitis following therapy with a proton pump inhibitor. Gastroenterology 1990; 98: A16
   Google Scholar
• Lundell L, Backman L, Ekström P, et al. Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared to ranitidine. Scand J Gastroenterol 1991; 26: 248–256
   PubMed Web of Science ®Google Scholar
• Bardhan K D, Morris P, Thompson M, et al. Omeprazole in the treatment of erosive oesophagitis refractory to high dose cimetidine and ranitidine. Gut 1990; 31: 745–749
   PubMed Web of Science ®Google Scholar
• Koop H, Wachtmann H, Eissele R, Arnold R. Efficacy and safety of long-term omeprazole maintenance therapy in H2-blocker-resistant reflux esophagitis healed by omeprazole. Dig Dis Sci 1991, In press
   Web of Science ®Google Scholar
• Johansson K E, Tibbling L. Maintenance treatment with ranitidine compared with fundoplication in gastroesophageal reflux disease. Scand J Gastroenterol 1986; 21: 779–788
   PubMed Web of Science ®Google Scholar
• Coley C M, Barry M J, Mulley AG. VA CSP Group #277. Medical vs. surgical therapy for gastroesophageal reflux disease: a decision analysis. Gastroenterology 1990; 89: A32
   Google Scholar
• Pellegrini C A, De Meester T R, Johnson L F, Skinner DB. Gastroesophageal reflux and pulmonary aspiration: incidence, functional abnormality and results of surgical therapy. Surgery 1979; 86: 110–119
   PubMed Web of Science ®Google Scholar
• Tardif C, Nouvet G, Denis P, et al. Surgical treatment of gastroesophageal reflux in ten patients with severe asthma. Respiration 1989; 56: 110–115
   PubMed Web of Science ®Google Scholar